US Syphilis Immunoassay Diagnostics Market Insight
US Syphilis Immunoassay Diagnostics market size is growing at a 6.78% CAGR, the public health problem of syphilis infection spreads because more people get tested for the disease and more medical facilities use automated immunoassay testing equipment.
US Syphilis Immunoassay Diagnostics Market Insights Forecasts to 2035
- The US Syphilis Immunoassay Diagnostics Market Size Was Estimated at USD 1185.3 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 6.78% from 2025 to 2035
- The US Syphilis Immunoassay Diagnostics Market Size is Expected to Reach USD 2283.3 Million by 2035
Notable Insights for US Syphilis Immunoassay Diagnostics Market
- By product type, the automated immunoassay systems segment dominated the market, generating approximately USD 495.7 million in revenue in 2024.
- By application, the hospital laboratories segment is expected to witness the fastest growth, supported by increasing patient testing volume and demand for accurate diagnostic solutions.
- Approximately 60% of diagnostic laboratories have adopted automated immunoassay platforms, while nearly 50% of healthcare providers rely on serological testing for early and accurate detection of syphilis. Additionally, the US holds a significant share of the global syphilis diagnostics market in 2024, reflecting strong public health initiatives.
Download the eBook (ToC)
- The US Syphilis Immunoassay Diagnostics Market experiences growth because government screening programs and public health awareness campaigns work together to improve early diagnosis and treatment while decreasing disease transmission rates.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the US Syphilis Immunoassay Diagnostics market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in US Syphilis Immunoassay Diagnostics Market
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd
- Danaher Corporation
- Becton, Dickinson and Company
- Siemens Healthineers
- bioMérieux
- Ortho Clinical Diagnostics
- Others
Recent Developments:
- In February 2026, Abbott Laboratories launched advanced immunoassay-based syphilis testing solutions with improved sensitivity and faster turnaround times to support large-scale screening programs.
- In September 2024, Siemens Healthineers launched their new automated immunoassay systems which enable laboratories to better detect sexually transmitted infections while increasing their operational efficiency and diagnostic performance.
Market Segmentation:
US Syphilis Immunoassay Diagnostics Market, By Product Type
- Automated Immunoassay Systems
- Reagents & Kits
- Others
US Syphilis Immunoassay Diagnostics Market, By Application
- Hospital Laboratories
- Diagnostic Laboratories
- Blood Banks
- Others
US Syphilis Immunoassay Diagnostics Market, By End User
- Hospitals
- Diagnostic Centers
- Research Institutes
Expert Views:
The US Syphilis Immunoassay Diagnostics Market will experience continuous expansion because both disease incidence rates and diagnostic system improvements will drive market growth. The experts believe that market expansion will benefit from two factors, which are automated systems and high-throughput testing and extended screening programs.